Heredopathia Atactica Polyneuritiformis (Refsum’s Disease)

  • W. Kahlke

Abstract

The first description of heredopathia atactica polyneuritiformis (HAP) was given 20 years ago by the Norwegian neurologist Sigvald Refsum. Main clinical features of this hereditary disorder are symptoms and signs of chronic polyneuropathy with progressive pareses of the distal parts of the extremities and distal muscular atrophy, and cerebellar involvement with ataxia and nystagmus. Deep tendon reflexes are absent. The cerebrospinal fluid protein is always considerably increased while the cell count is normal (albuminocytologic dissociation). Other clinical signs include atypical or (less frequently) typical pigmentary retinitis with night blindness and concentric narrowing of the visual fields, skeletal malformations which are usually symmetrical in approximately 75% of cases, and cardiac involvement which may give rise to various electrocardiographic abnormalities. Further facultative symptoms consist of impairment of hearing and sense of smell, skin changes resembling ichthyosis and other non-characteristic changes.

Keywords

Cholesterol Chlorophyll Neuropathy Glaucoma Cataract 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alexander, W. S.: Phytanic acid in Refsum’s syndrome. J. Neurol. Neurosurg. Psychiat. (1966) 29, 412. Personal communication.PubMedGoogle Scholar
  2. Alfano, J. E., and J. P. Berger: Retinitis pigmentosa, ophthalmoplegia, and spastic quadriplegia. Amer. J. Ophthal. 43, 231 (1957).PubMedGoogle Scholar
  3. Ashenhurst, E., J. Millar, and T. Milliken: Refsum’s syndrome affecting a brother and two sisters. Brit. Med. J. 1958/11, 415.Google Scholar
  4. Barnard, R. I., and R. O. Scholz: Ophthalmoplegia and retinal degeneration. Amer. J. Ophthal. 27, 621 (1944).Google Scholar
  5. Baum, J. L., M. Tannenbaum, and E. H. Kolodny: Refsum’s syndrome with corneal involvement. Amer. J. Ophthal. 60, 699 (1965).PubMedGoogle Scholar
  6. Bergmann, E.: Studies in Heredo ataxia. Uppsala Läk.-Fören. Förh. 26, 1 (1921).Google Scholar
  7. Billeter, M., W. Bolliger u. C. Martius: Untersuchungen über die Umwandlung von verfütterten K-Vitaminen durch Austausch der Seitenkette und die Rolle der Darmbakterien hierbei. Biochem. Z. 340, 290 (1964).PubMedGoogle Scholar
  8. Billings, J. J., J. O’Callaghan, and K. O’Day: Refsum’s syndrome: Heredopathia atactica polyneuritiformis. Trans. Ophthal. Soc. Aust. 17, 131 (1957).Google Scholar
  9. Bjurstam, N., B. Hallgren, R. Ryhage u. S. Ställberg-Stenhagen: Cit. by Stenhagen: Massenspectrometrie als Hilfsmittel bei der Strukturbestimmung organischer Verbindungen, besonders bei Lipiden und Peptiden. Z. analyt. Chem. 181, 462 (1961).Google Scholar
  10. Blanc, M., A. Seilhcan, J. Julien et Bourgeois: Maladie de Refsum: Limites du syndrome de Guillain-Barré. Ann. méd.-psychol. 1, 732 (1963).Google Scholar
  11. Cammermeyer, J.: Om de anatomiske Gunn i to tilfelle av dr. Refsum’s materiale av “et tidligere ikke beskrevet ( ?) familiaert syndrom”. Nord. Med. 29, 617 (1946).Google Scholar
  12. Cammermeyer, J.: Neuropathological changes in hereditary neuropathies: manifestation of the syndrome heredopathia atactica polyneuritiformis in the presence of interstitial hypertrophic polyneuropathy. J. Neuropath, exp. Neurol. 15, 340 (1956).Google Scholar
  13. Cammermeyer, J. , W. Haymaker, and S. Refsum: Heredopathia atactica polyneuritiformis: The neuropathology changes in three adults and one child. Amer. J. Path. 30, 643 (1954).Google Scholar
  14. Cason, J., G. Sumrell, C. P. Allen, G. A. Gillies and S. Elberg: Certain characteristics of the fatty acids from the lipides of the tubercle bacillus. J. biol. Chem. 205, 435 (1953).PubMedGoogle Scholar
  15. Chamlin, M., and E. Billet: Ophthalmoplegia and pigmentary degeneration of the retina. Arch. Ophthal. 43, 217 (1950).PubMedGoogle Scholar
  16. Clark, D. B.: Heredopathia atactica polyneuritiformis. J. Neuropath, exp. Neurol. 9,385 (1951).Google Scholar
  17. Clauss, O.: Über hereditäre cerebellare Ataxie in Verbindung mit Pigmentdegeneration und Degeneration des N. cochlearis. Z. Ges. Neurol. Psychiat. 23, 294 (1924).Google Scholar
  18. Dereux, J.: Maladie de Refsum. VII. Int. Congres Neurol., Roma. Excerpta med. (Amst.). Int. Congr. Series 38, 103 (1961).Google Scholar
  19. Dereux, J.: La maladie de Refsum. Rev. Neurol. 109, 599 (1963).Google Scholar
  20. Dereux, J.: Personal communication (1965).Google Scholar
  21. Dereux, J. and J. E. Grüner: Maladie de Refsum. Étude d’une biopsie nerveuse au microscope électronique. Rev. Neurol. 109, 564 (1963a).Google Scholar
  22. Dereux, J. and J. E. Grüner: Maladie de Refsum. Étude biopsique d’un nerf au microscope électronique. Soc. Franç. de Neurologie, Séance du novembre 1963 b.Google Scholar
  23. Duncan, W. R. H., and G. A. Garton: Blood lipids. 3. Plasma lipids of the cow during pregnancy and lactation. Biochem. J. 89, 414 (1963).PubMedGoogle Scholar
  24. Dureux, J. B.: Les génopathies et embryopathies neuro-ophtalmiques. Encéphale 3,253 (1957).Google Scholar
  25. Edström, R., O. Gröntoft, and H. Sandring: Refsum’s disease. Three siblings, one autopsy. Acta psychiat. scand. 34, 40 (1959).Google Scholar
  26. Eldjarn, L.: Heredopathia atactica polyneuritiformis (Refsum’s disease) — A defect in the omega-oxidation mechanism of fatty acids. Scand. J. Clin. Lab. Invest. 17, 178 (1965a).PubMedGoogle Scholar
  27. Eldjarn, L.: Biokjemiske synspunkter pa phytansyrens opprinelse. Nord. Med. 73, 571 (1965b).Google Scholar
  28. Eldjarn, L. K. Try, and O. Stokke: Abnormal serum protein pattern in Refsum’s disease. Scand. J. Clin. Lab. Invest. 17, Suppl. 86, 137 (1965a).Google Scholar
  29. Eldjarn, L. K. Try, and O. Stokke: Studies on the defect in the degradation of branched-chain fatty acid structures in Refsum’s disease. Scand. J. Clin. Lab. Invest. 17, Suppl. 86, 138 (1965 b).Google Scholar
  30. Eldjarn, L. K. Try, and O. Stokke: The existence of an alternative pathway for the degradation of branched-chain fattyacids, and its failure in heredopathia atactica polyneuritiformis (Refsum’s disease). Biochim. Biophys. Acta (Amst.) 116, 395 (1966a).Google Scholar
  31. Eldjarn, L., K. Try, O. Stokke, A. M. Munthe-Kaas, S. Refsum, D. Steinberg, J. Avigan, and C. Mize: Dietary effects on serum-phytanic acid levels and on clinical manifestations in heredopathia atactica polyneuritiformis. Lancet 1966 b/I, 691.Google Scholar
  32. Erdbrink, W. L.: Ocular myopathy associated with retinitis pigmentosa. Arch. Ophthal. 57, 335 (1957).Google Scholar
  33. Fisher, M.: Unusual variant of acute idiopathic polyneuritis syndrome of ophthalmoplegia, ataxia and areflexia. New. Engl. J. Med. 255, 57 (1956).PubMedGoogle Scholar
  34. Fleming, R.: Refsum’s syndrome. An unusual hereditary neuropathy. Neurology (Minneap.) 7, 476 (1957).Google Scholar
  35. Franceschetti, A., J. Francois et J. Babel: Les hérédo-dégénérescenses chorio-rétiniennes (dégénérescenses tapéto-rétiniennes), p. 851 et 1085. Paris: Masson 1963.Google Scholar
  36. Freycon, F.: Revue critique. Le syndrome de Refsum. Pédiatrie 16, 411 (1961).PubMedGoogle Scholar
  37. Gellerstedt, in: Kjellson (1953).Google Scholar
  38. Globus, J. H.: Ein Beitrag zur Histopathologic der amaurotischen Idiotie (mit besonderer Berücksichtigung der Beziehungen zu den hereditären Kleinhirnerkrankungen und zur Merzbacher-Pelizaeusschen Krankheit). Z. Ges. Neurol. Psychiat. 85, 424 (1923).Google Scholar
  39. Globus, J. H.: Amaurotic family idiocv. J. Mt Sinai Hosp. 9, 451 (1942); cited after Reese and Bareta, 1950.Google Scholar
  40. Goodwin, R. F., and C. M. Poser: Ophthalmoplegia, ataxia and areflexia. J. Amer. Med. Ass. 186, 258 (1963).Google Scholar
  41. Gordon, N., and R.E.B. Hijdson: Refsum’s Syndrome.Heredopathia atactica polyneuritiformis. A report of three cases, including a study of the cardiac pathology. Brain 82, 41 (1959).PubMedGoogle Scholar
  42. Greenfield, J. G.: Diseases of the lower motor and sensory neurones (peripheral neuritis and neuropathy) in hypertrophic interstitial neuropathy of Déjérine and Sottas (heredopathia atactica polyneuritiformis Refsum). In : Neuropathology. Ed. : Arnold, p. 607. London 1958.Google Scholar
  43. Hallervorden, J.: Die hereditäre Ataxie. In: Bumke, O., and O. Foerster (Herausgeb.): Handbuch der Neurologie, Bd. 16, S. 657. Berlin: Springer 1936.Google Scholar
  44. Hansen, R. P.: 3, 7, 11, 15-tetramethylhexadecanoic acid: its occurrence in sheep fat. N. Z. J. Sci. 8, 158 (1965a).Google Scholar
  45. Hansen, R. P.: 3, 7, 11, 15-tetramethylhexadecanoic acid: its occurrence in the tissues of humans afflicted with Refsum’s syndrome. Biochem. Biophys. Acta (Amst.) 106, 304 (1965b).Google Scholar
  46. Hansen, R. P.: Occurrence of 3, 7, 11, 15-tetramethylhexadecanoic acid in ox perinephric fat. Chem. Industry 1965 c, 303.Google Scholar
  47. Hansen, R. P. and F. B. Shorland: The branched chain fatty acids of butter fat. II. The isolation of a multibranched C20 saturated fatty acid fraction. Biochem. J. 50, 358 (1951).Google Scholar
  48. Hansen, R. P. and F. B. Shorland: Biochem. J. 55, 662 (1953); cited after Hansen (1965 b).Google Scholar
  49. Hansen, R. P. and F. B. Shorland and J. D. Morrison: Identification of a C20 multibranched fatty acid from butterfat as 3, 7, 11, 15-tetramethylhexadecanoic acid. J. Dairy Res. 32, 21 (1965).Google Scholar
  50. Härders, H., u. H. Dieckmann: Heredopathia atactica polyneuritiformis. Klinik und Diagnostik des Refsum-Syndroms. Dtsch. Med. Wschr. 89, 248 (1964).PubMedGoogle Scholar
  51. Heycock, J. B., and J. Wilson: Diabetes mellitus in a child showing features of Refsum’s syndrome. Arch. Dis. Childh. 33, 320 (1958).PubMedGoogle Scholar
  52. Jager, B. V., H. L. Fred, R. B. Butler, and W. H. Carnes: Occurrence of retinal pigmentation, ophthalmoplegia, ataxia, deafness and heart block. Report of a case with findings at autopsy. Amer. J. Med. 29, 888 (1960).PubMedGoogle Scholar
  53. Jéquier, M., et E. B. Streiff: Paraplégie, dystrophie scelettique et dégénérescense tapétorétinienne familiale. Arch. Klaus-Stift. Vererb.-Forsch. 22, 129 (1947).Google Scholar
  54. Kahlke, W.: Über das Vorkommen von 3, 7, 11, 15-Tetramethylhexadecansäure im Blutserum bei Refsum-Syndrom. Klin. Wschr. 41, 783 (1963).Google Scholar
  55. Kahlke, W.: Refsum-Syndrom. — Lipoidchemische Untersuchungen bei 9 Fällen. Klin. Wschr. 42, 1011 (1964a).PubMedGoogle Scholar
  56. Kahlke, W.: Unpublished results (1964b).Google Scholar
  57. Kahlke, W.: Lipoide (Lipide). Fortschr. Med. 83, 517, 552 (1965).Google Scholar
  58. Kahlke, W.: Lipoide (Lipide). Fortschr. Med. 83, 517, 634 (1965).Google Scholar
  59. Kahlke, W. and R. Richterich: Refsums disease (heredopathia atactica polyneuritiformis) : An inborn error of lipid metabolism with storage of 3, 7, 11, 15-tetramethylhexadecanoic acid. II. Isolation and identification of the storage product. Amer. J. Med. 39, 237 (1965).PubMedGoogle Scholar
  60. Kahlke, W. and H. Wagener: Destribution of 3, 7, 11, 15-tetramethylhexadecanoic acid between plasma lipoproteins in Refsum’s syndrome. In: Protides of the biological fluids, XIII. Colloquium Brugge 1965, p. 351. Ed.: H. Peeters. Amsterdam: Elsevier 1966a.Google Scholar
  61. Kahlke, W. and H. Wagener: Conversion of 3H-phytol to phytanic acid and its incorporation into plasma fractions in heredopathia atactica polyneuritiformis. Metabolism 15, 687 (1966 b).PubMedGoogle Scholar
  62. Kahlke, W. and H. Wagener u. H. Dieckmann: Untersuchungen über den Phytolstoffwechsel bei der Lipidose Heredopathia atactica polyneuritiformis (Refsum-Syndrom) : Umwandlung von 3H-Phytol in die 3. 7. 11. 15-Tetramethylhexadecansäure (Phytansäure) der Plasmalipoidfraktionen. Klin. Wschr. 43, 1345 (1965).PubMedGoogle Scholar
  63. Kearns, T. P., and G. P. Sayre: Retinitis pigmentosa, external ophthalmoplegia and complete heart block. Arch. Ophthal. 60, 280 (1958).Google Scholar
  64. Kjellson, L.: Refsum sjuledom. Refsum’s disease. Nord. Med. 49, 460 (1953).PubMedGoogle Scholar
  65. Klenk, E., u. W. Kahlke: Über das Vorkommen der 3,7,11,15-Tetramethylhexadecansäure (Phytansäure) in den Cholesterinestern und anderen Lipoidfraktionen der Organe bei einem Krankheitsfall unbekannter Genese. Verdacht auf Heredopathia atactica polyneuritiformis (Refsum-Syndrom). Hoppe Seylers Z. physiol. Chem. 333, 133 (1963).PubMedGoogle Scholar
  66. Lough, A. K.: Isolation of 3, 7, 11, 15-tetramethylhexadecanoic acid from ox plasma. Biochem. J. 86, 14 (1963).Google Scholar
  67. Lough, A. K.: Blood lipids. 4. The isolation of 3, 7, 11, 15-tetramethylhexadecanoic acid (phytanic acid) from ox-plasma lipids. Biochem. J. 91, 584 (1964).PubMedGoogle Scholar
  68. Nordhagen, E., and J. Gröndahl: Heredopathia atactica polyneuritiformis (Refsum’s disease). Acta Ophthal. (Kbh.) 42, 629 (1964).Google Scholar
  69. Olesen, Th. B.: A case of heredopathia atactica polyneuritiformis (Morbus Refsum). Acta psychiat. scand. 32, 83 (1957).Google Scholar
  70. Pecker, J., Y. M. Feuvrier et Y. Lehuerou: Maladie de Refsum. Diagnostic avec certaines polyradiculonéurites à rechutes. Rev. Neurol. 109, 1 (1963).Google Scholar
  71. Petit, J. F.: Le syndrome de Refsum. Les manifestations ophthalmologiques à propos d’une observation. These, Reimes, No. 354 (1963).Google Scholar
  72. Prior, I.: Personal communication (1966).Google Scholar
  73. Ravin, B., and H. Schwartz: Case report: Refsum’s disease. Anesthesiology 23, 269 (1962).PubMedGoogle Scholar
  74. Reese, H., and J. Bareta: Heredopathia atactica polyneuritiformis. J. Neuropath, exp. Neurol. 9, 385 (1950).Google Scholar
  75. Refsum, S.: Staff meeting Rikshospitalet, Oslo, June 1944.Google Scholar
  76. Refsum, S.: Heredoataxia hemeralopica polyneuritiformis — et tidligere ikke beskrevet familiaert syndrom ? En forelobig meddelelse. Nord. Med. 28, 2682 (1945).Google Scholar
  77. Refsum, S.: Et tidligere ikke beskrevet ( ?) familiaert syndrom: “Heredoataxia hemeralopica polyneuritiformis”. Nord. Med. 29, 617 (1946a).Google Scholar
  78. Refsum, S.: Heredopathia atactica polyneuritiformis. A familial syndrome not hitherto described. Acta psychiat. scand. Suppl. 38 (1946b).Google Scholar
  79. Refsum, S.: Heredopathia atactica polyneuritiformis. J. nerv. ment. Dis. 116, 1046 (1952).PubMedGoogle Scholar
  80. Refsum, S.: Heredopathia atactica polyneuritiformis. Acta Genet. (Basel) 7, 344 (1957).Google Scholar
  81. Refsum, S.: Heredopathia atactica polyneuritiformis. Wld Neurol. 1, 334 (1960).Google Scholar
  82. Refsum, S.: Heredopathia atactica polyneuritiformis, en metabolisk betinget nervesykdom. Nord. Med. 73, 570 (1965).Google Scholar
  83. Refsum, S.: Personal communication (1966).Google Scholar
  84. Refsum, S., L. Salomonsen, and M. Skatvedt: Heredopathia atactica polyneuritiformis in children; a preliminary communication. J. Pediat. 35, 335 (1949).PubMedGoogle Scholar
  85. Richterich, R., W. Kahlke, P. van Mechelen u. E. Rossi: Refsum’s Syndrom (Heredopathia atactica polyneuritiformis): Ein angeborener Defekt im Lipoidstoffwechsel mit Speicherung von 3, 7,11, 15-Tetramethylhexadecansäure. Klin. Wschr. 41, 800 (1963).PubMedGoogle Scholar
  86. Richterich, R., W. Kahlke, P. van Mechelen u. E. Rossi, H. Moser, and E. Rossi: Refsum’s disease (heredopathia atactica polyneuritiformis). Aninborn error of lipid metabolism with storage of 3, 7, 11, 15-tetramethylhexadecanoic acid. A review of the clinical findings. Humangenetik 1, 322 (1965 a).PubMedGoogle Scholar
  87. Roos, B., P. van Mechelen and E. Rossi: Refsum’s disease (heredopathia atactica polyneuritiformis): An inborn error of lipid metabolism with storage of 3, 7, 11, 15-tetramethylhexadecanoic acid. I. Report of a case. Amer. J. Med. 39, 230 (1965 b).Google Scholar
  88. Roos, B., P. van Mechelen and E. Rossi and R. Richterich: Refsum’s disease (heredopathia atactica polyneuritiformis): Aninborn error of lipid metabolism with storage of 3, 7, 11, 15-tetramethylhexadecanoic acid. V. Biochemical, histological and electron microscopical studies on biopsy material from the liver and the kidney. (In preparation.) Cited by Richterich et al. (1965a).Google Scholar
  89. Roth, M.: On a possible relationship between hereditary ataxia and peroneal muscular atrophy; with a critical review of the problems of “intermediate forms” in the degenerative disorders of the central nervous system. Brain 71, 416 (1948).PubMedGoogle Scholar
  90. Sabottratjd, O.: Personal communication (1965/1966).Google Scholar
  91. Saifer, A., and S. Gerstenfield: Photometric determination of sialic acid in serum and in cerebrospinal fluid with the thiobarbituric acid method. Clin. chim. Acta 7, 467 (1962).PubMedGoogle Scholar
  92. Sakagamy, T., and D. B. Zilversmith: Separation of dog serum lipoproteins by ultracentrifugation, dextran sulfate precipitation, and paper electrophoresis. J. Lipid Res. 3, 111 (1962).Google Scholar
  93. Salomonsen, L., and M. Skatvedt: Four cases of heredopathia atactica polyneuritiformis (Refsum) in children. Acta paediat. (Uppsala) Suppl. 77,44 (1949).Google Scholar
  94. Sauer: Personal communication (unpublished data) 1964.Google Scholar
  95. Saunders, M., and M. Rake: Familial Guillain-Barré Syndrome. Lancet 1965/11,1106.Google Scholar
  96. Sjögren, T.: Klinische und erbbiologische Untersuchungen über die Heredoataxien. Actapsychiat. scand. Suppl. 27,1 (1943).Google Scholar
  97. Smith, J. L., and F. B. Walsh: Syndrome of external ophthalmoplegia, ataxia, and areflexia (Fisher). Arch. Ophthal. 58,109 (1957).Google Scholar
  98. Sonneveld, Z. W., P. Haverkamp-Begeman, G. J. van Beers, R. Ketjning, and J. C. M. Schogt: 3.7.11.15-tetramethylhexadecanoic acid: a constituent of butter-fat. J. Lipid. Res. 3, 351 (1962).Google Scholar
  99. Steinberg, D.: Remarks on the biochemical basis of Refsum’s disease. Nord. Med. 73, 571 (1965).Google Scholar
  100. Steinberg, D., J. Avigan, C. Mize, and J. Baxter: Phytanic acid formation and accumulation in phytolfed rats. Biochem. Biophys. Res. Commun. 19, 412 (1965 a).PubMedGoogle Scholar
  101. Steinberg, D., J. Avigan, C. Mize, and J. Baxter, L. Eldjarn, K. Try, and S. Refsum: Conversion of U-C14-phytol to phytanic acid and its Oxydation in heredopathia atactica polyneuritiformis. Biochem. Biophys. Res. Commun. 19, 783 (1965b).PubMedGoogle Scholar
  102. Stoffel, W., and W. Kahlke: The transformation of phytol into 3, 7, 11,15-tetramethyl-hexadecanoic (phytanic) acid in heredopathia atactica polyneuritiformis (Refsum’s syndrome). Biochem. Biophys. Res. Commun. 19, 1 (1965).Google Scholar
  103. Thiébaut, J., J. Lemoyne et L. Guillatjmat: Deux syndromes oto-neuro-oculistiques d’origene congenitale. Leurs rapports avec les placomatoses de van der Stolve et autres dysplasies neuro-ectodermiques. Rev. Neurol. 72, 71 (1939).Google Scholar
  104. Thiébaut, J., J. Lemoyne et L. Guillatjmat: Maladie de Refsum. Rev. Neurol. 104, 152 (1961).Google Scholar
  105. Toussaint, D., C. Coers et N. Toppet: Heredopathia atactica polyneuritiformis (syndrome de Refsum). Constatation cliniques et biopsiques. Bull. Soc. beige Ophthal. 122,383 (1959).Google Scholar
  106. Try, K., O. Stokke, and L. Eldjarn: Two new cases of heredopathia atactica polyneuritiformis (Refsums syndrome). Demonstrated phytanic acid accumulation. Scand. J. Clin. Lab. Invest. 17, Suppl. 86,195 (1965).Google Scholar
  107. Veltema, A. N., et A. Verjaal: Sur un cas d’hérédopathie ataxique polyneuritique. Maladie de Refsum. Rev. Neurol. 104,15 (1961).Google Scholar
  108. Wald, G.: The visual function of the vitamins A. Vitam. and Horm. 18, 417 (1960).Google Scholar
  109. Walsh, F. B.: Clinical Neuro-Ophthalmology. Baltimore: Williams & Wilkins 1947.Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1967

Authors and Affiliations

  • W. Kahlke

There are no affiliations available

Personalised recommendations